Innovative Product Portfolio Vector Laboratories offers a diverse and high-quality range of reagents, bioconjugation technologies, and molecular engineering solutions that address complex challenges in diagnostics and therapeutics, making them an attractive partner for organizations seeking cutting-edge biotech tools.

Strategic Collaborations Recent partnerships with companies like Saint-Gobain and collaborations with Navinci Diagnostics highlight opportunities to cross-sell advanced spatial proteomic and bioconjugation solutions to existing partners and new clients involved in research and manufacturing.

Recent Industry Recognition Winning the 2026 CiteAb Innovation Award and showcasing at major industry events signals strong innovation capabilities, which can be leveraged to position Vector Labs as a leader in biomarker discovery and glycan detection markets.

Expanding Market Reach Through the 2024 merger with Absolute Biotech and expansion into the UK and European markets, Vector Labs is increasing its geographic footprint, presenting sales opportunities across wider international biotech and research markets.

Growing Research Focus With recent developments in spatial proteomic tools and a strategic emphasis on biomarker discovery, there is a clear demand for advanced reagents and custom solutions, presenting opportunities to target biotech firms, research institutions, and diagnostics companies investing in cutting-edge proteomics and glycoscience research.